3,7-dimethyl-1-propargylxanthine has been researched along with Alloxan Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansell, P; Palm, F; Persson, P | 1 |
1 other study(ies) available for 3,7-dimethyl-1-propargylxanthine and Alloxan Diabetes
| Article | Year |
|---|---|
Adenosine A2 receptor-mediated regulation of renal hemodynamics and glomerular filtration rate is abolished in diabetes.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Arterioles; Diabetes Mellitus, Experimental; Glomerular Filtration Rate; Hemodynamics; Kidney; Male; Mice; Mice, Inbred C57BL; Receptors, Adenosine A2; Renal Circulation; Theobromine | 2013 |